Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells

Cardiovascular Research

Volumn 90, Issue 3, 2011, Pages 457-463

  Dunoyer Geindre, Sylvie ^a   Kruithof, Egbert K O ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

DNA methylation; Endothelial cell; Histone acetylation; Tissue type plasminogen activator

Indexed keywords

ANACARDIC ACID; ANTIBODY; BUTYRIC ACID; DINUCLEOTIDE; DNA; ENTINOSTAT; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H3; HISTONE H4; TISSUE PLASMINOGEN ACTIVATOR; TRICHOSTATIN A;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENDOTHELIUM CELL; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CELLS, CULTURED; DNA METHYLATION; DNA PRIMERS; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; HEPATOCYTES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79957492651     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr028     Document Type: Article

References (30)

1. Wall U, Jern S, Tengborn L, Jern C. Evidence of a local mechanism for desmopressin-induced tissue- type plasminogen activator release in human forearm. Blood 1998;91:529-537. (Pubitemid 28053375)
2. Tranquille N, Emeis JJ. The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor. Thromb Haemost 1993;69:259-261. (Pubitemid 23069004)
3. Giles AR, Nesheim ME, Herring SW, Hoogendoorn H, Stump DC, Heldebrant CM. The fibrinolytic potential of the normal primate following the generation of thrombin in vivo. Thromb Haemost 1990;63:476-481. (Pubitemid 20214729)
4. Kruithof EK, Mestries JC, Gascon MP, Ythier A. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation-effect of interleukin 6. Thromb Haemost 1997;77:905-910. (Pubitemid 27239113)
5. Emeis JJ, van den Eijnden-Schrauwen Y, van den Hoogen CM, de Priester W, Westmuckett A, Lupu F. An endothelial storage granule for tissue-type plasminogen activator. J Cell Biol 1997;139:245-256. (Pubitemid 27444095)
6. Rosnoblet C, Vischer UM, Gerard RD, Irminger JC, Halban PA, Kruithof EK. Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. Arterioscler Thromb Vasc Biol 1999;19:1796-1803. (Pubitemid 29323842)
7. Datta YH, Youssoufian H, Marks PW, Ewenstein BM. Targeting of a heterologous protein to a regulated secretion pathway in cultured endothelial cells. Blood 1999; 94:2696-2703. (Pubitemid 29477298)
8. Huber D, Cramer EM, Kaufmann JE, Meda P, Massé JM, Kruithof EK et al. Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo. Blood 2002;99:3637-3645. (Pubitemid 34534533)
9. Dichek D, Quertermous T. Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. Blood 1989;74:222-228. (Pubitemid 19187432)
10. Kooistra T, Bosma PJ, Toet K, Cohen LH, Griffioen M, van den Berg E et al. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of protooncogenes c-jun and c-fos. Arterioscler Thromb 1991;11:1042-1052.
11. Bulens F, Nelles L, Van den Panhuyzen N, Collen D. Stimulation by retinoids of tissuetype plasminogen activator secretion in cultured human endothelial cells: Relations of structure to effect. J Cardiovasc Pharmacol 1992;19:508-514.
12. Pepper MS, Rosnoblet C, Di Sanza C, Kruithof EK. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells. Thromb Haemost 2001;86:702-709. (Pubitemid 32743288)
13. Arts J, Lansink M, Grimbergen J, Toet KH, Kooistra T. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem J 1995;310:171-176.
14. Ordovás JM, Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol 2010;7: 510-519.
15. Yan MS, Matouk CC, Marsden PA. Epigenetics of the vascular endothelium. J Appl Physiol 2010;109:916-926.
16. Bruneau BG. Epigenetic regulation of the cardiovascular system: Introduction to a review series. Circ Res 2010;107:324-326.
17. Ellis L, Hammers H, Pili R. Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett 2009;280:145-153.
18. Marks PA, Xu WS. Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem 2009;107:600-608.
19. Dinarello CA. Anti-inflammatory agents: Present and future. Cell 2010;140:935-950.
20. Dunoyer-Geindre S, Kruithof EK, Galve-de Rochemonteix B, Rosnoblet C, Gruenberg J, Reber G et al. Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells. Thromb Haemost 2001;85:903-907. (Pubitemid 32421826)
21. Fish RJ, Kruithof EK. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors. BMC Mol Biol 2004;5:9.
22. Cedar H, Bergman Y. Linking DNA methylation and histone modification: Patterns and paradigms. Nat Rev Genet 2009;10:295-304. Review.
23. Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: Molecular mechanisms of action. Oncogene 2007;26:5541-5552. (Pubitemid 47255934)
24. Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004;279: 51163-51171. (Pubitemid 40017859)
25. Medcalf RL, Rüegg M, Schleuning WD. A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP. J Biol Chem 1990;265:14618-14626.
26. Arts J, Herr I, Lansink M, Angel P, Kooistra T. Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro. Nucleic Acids Res 1997;25:311-317. (Pubitemid 27303323)
27. Costa M, Shen Y, Maurer F, Medcalf RL. Transcriptional regulation of the tissue-type plasminogen-activator gene in human endothelial cells: Identification of nuclear factors that recognise functional elements in the tissue-type plasminogen-activator gene promoter. Eur J Biochem 1998;258:123-131. (Pubitemid 28538316)
28. Pan W, Chang MJ, Booyse FM, Grenett HE, Bradley KM, Wolkowicz PE et al. Quercetin induced tissue-type plasminogen activator expression is mediated through Sp1 and p38 mitogen-activated protein kinase in human endothelial cells. J Thromb Haemost 2008;6:976-985. (Pubitemid 351689920)
29. Sebova K, Fridrichova I. Epigenetic tools in anticancer therapy. Anticancer Drugs 2010; 21:565-577. Review.
30. Narayan P, Dragunow M. Pharmacology of epigenetics in brain disorders. Br J Pharmacol 2010;159:285-303.